katalysthealthcareslifesciences.com
The Biotherapeutics and Genetic Medicine Group is seeking a highly motivated scientist to initiate and advance a lentiviral delivery platform for gene therapy. The role involves designing and engineering lentiviral vectors, managing production with internal and CRO resources, and developing analytical and cell‑based screening assays while maintaining detailed documentation and compliance in a BSL‑2 environment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for katalysthealthcareslifesciences.com.
katalysthealthcareslifesciences.com didn’t post a salary, so this is our estimate from similar listings.
43% above the average for this role